Uplizna 100 mg concentrate for solution for infusion
- Licence status
- Active substances
- Inebilizumab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/21/1602/001
- Licence holder
- Amgen Europe B.V.,
Product documents
Licence information
- ATC code
- L04AA Selective immunosuppressants, L04AA47 Inebilizumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/04/2022